FDA Adverse Event Injury Summary report: N

INFINION CX

MDR report key: 12382525 · Received August 30, 2021

Report

Report Number
3006630150-2021-04822
Event Type
Injury
Date Received
August 30, 2021
Date of Event
April 13, 2021
Report Date
August 30, 2021
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION
Product Code
LGW
UDI-DI
08714729861638
PMA / PMN Number
P030017
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CO, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENT INVOLVED IN THE EVENT: PRODUCT FAMILY: SCS-LINEAR LEADS: UPN: M365SC2317700, MODEL: SC-2317-70, SERIAL: (B)(4), BATCH: 7071590.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT HAD INADEQUATE STIMULATION DESPITE MULTIPLE REPROGRAMMING ATTEMPTS DUE TO LEAD MIGRATION THAT WAS CONFIRMED VIA X-RAY. THE PATIENT UNDERWENT A LEAD REPLACEMENT PROCEDURE AND WAS DOING WELL POSTOPERATIVELY. THE EXPLANTED LEADS WERE DISCARDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1284177 INFINION CX STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF LGW BOSTON SCIENTIFIC NEUROMODULATION SC-2317-70 7070970 08714729861638

Patients

Seq Age Sex Outcome Treatment
1 76 YR Required Intervention